Jennell U. White, PhD1,2, Xiufeng Gao, MD3*, Kerry Bellemare4*, Gershwin Theophilus Blyden, MD, PhD5*, Lanetta Bronté-Hall, MD, MPH, MSPH6, Alexander K Glaros, MD7*, Andrew D. Campbell, MD8, Olufunke Y. Martin, MD9, Sharon Pennington, MD10, Ofelia A. Alvarez, MD11, Indryas L. Woldie, MD12,13, Nnamdi Okeke, PharmD14* and Patrick C. Hines, MD, PhD1,15
1Functional Fluidics Inc, Detroit, MI
2Department of Pharmacology/Pediatrics, Wayne State University, Grosse Pointe Woods, MI
3Functional Fluidics, Detroit, MI
4Pharmacology, Wayne State University School of Medicine, Detroit
5Foundation for Sickle Cell Disease Research, Miami, FL
6The Foundation for Sickle Cell Disease Research, Hollywood, FL
7Central Michigan University College of Medicine, Mount Pleasant, MI
8Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC
9Center for Cancer and Blood Disorders, Children's Medical Center Dallas, Dallas, TX
10Mississippi Center For Advanced Medicine, Madison, MS
11Department of Pediatrics, Division of Pediatric Hematology/Oncology, Univ. of Miami School of Med., Miami, FL
12Wayne State University, Detroit
13Karmanos, Detroit, MI
14Functional Fluidics, Detroit
15Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI